CAMP – CalAmp Corp.
CAMP — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
2.35
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
6.26
Price
0.4
Target Price
8.2
Analyst Recom
1.33
Performance Q
-22.37
Upside
-1,315.9%
Beta
0.41
Ticker: CAMP
19 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | CAMP | 6.3 | N/A | N/A | 0 |
| 2026-03-10 | CAMP | 6.03 | N/A | N/A | 0 |
| 2026-03-11 | CAMP | 5.47 | N/A | N/A | 0 |
| 2026-03-12 | CAMP | 5.35 | N/A | N/A | 0 |
| 2026-03-13 | CAMP | 5.38 | N/A | N/A | 0 |
| 2026-03-17 | CAMP | 5.55 | N/A | N/A | 0 |
| 2026-03-18 | CAMP | 5.34 | N/A | N/A | 0 |
| 2026-03-19 | CAMP | 5.23 | N/A | N/A | 0 |
| 2026-03-20 | CAMP | 4.93 | N/A | N/A | 0 |
| 2026-03-23 | CAMP | 4.72 | N/A | N/A | 0 |
| 2026-03-24 | CAMP | 4.58 | N/A | N/A | 0 |
| 2026-03-25 | CAMP | 4.74 | N/A | N/A | 0 |
| 2026-03-26 | CAMP | 4.52 | N/A | N/A | 0 |
| 2026-03-27 | CAMP | 4.34 | N/A | N/A | 0 |
| 2026-03-30 | CAMP | 4 | N/A | N/A | 0 |
| 2026-03-31 | CAMP | 4.49 | N/A | N/A | 0 |
| 2026-04-01 | CAMP | 4.47 | N/A | N/A | 0 |
| 2026-04-02 | CAMP | 4.48 | N/A | N/A | 0 |
| 2026-04-06 | CAMP | 4.47 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
19 items
«
‹
Current Page1 of 1
›
»
No data found
20 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | CAMP | 21.69 | 26.12 | 2.80 |
| 2026-03-10 | CAMP | 21.69 | 26.12 | 2.80 |
| 2026-03-11 | CAMP | 21.69 | 26.12 | 2.51 |
| 2026-03-12 | CAMP | 10.35 | 26.12 | 2.51 |
| 2026-03-13 | CAMP | 10.35 | 26.12 | 2.51 |
| 2026-03-17 | CAMP | 0.00 | 26.12 | 2.51 |
| 2026-03-18 | CAMP | 0.00 | 26.12 | 2.51 |
| 2026-03-19 | CAMP | 0.00 | 26.12 | 2.51 |
| 2026-03-20 | CAMP | 0.00 | 26.12 | 2.51 |
| 2026-03-23 | CAMP | 0.00 | 26.12 | 2.51 |
| 2026-03-24 | CAMP | 0.00 | 26.12 | 2.51 |
| 2026-03-25 | CAMP | 0.00 | 26.12 | 2.35 |
| 2026-03-26 | CAMP | 0.00 | 26.12 | 2.35 |
| 2026-03-27 | CAMP | 0.00 | 26.12 | 2.35 |
| 2026-03-30 | CAMP | 0.00 | 26.12 | 2.35 |
| 2026-03-31 | CAMP | 0.00 | 26.12 | 2.35 |
| 2026-04-01 | CAMP | 0.00 | 26.12 | 2.35 |
| 2026-04-02 | CAMP | 0.00 | 26.12 | 2.35 |
| 2026-04-06 | CAMP | 0.00 | 26.12 | 2.35 |
| 2026-04-07 | CAMP | 0.00 | 26.12 | 2.35 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
20 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-2.04
Avg. EPS Est. Next Quarter
-1.15
Insider Transactions
Institutional Transactions
26.12
Beta
0.41
Average Sales Estimate Current Quarter
51
Average Sales Estimate Next Quarter
53
Fair Value
Quality Score
22
Growth Score
28
Sentiment Score
11
Actual DrawDown %
99.9
Max Drawdown 5-Year %
-99.9
Target Price
8.2
P/E
Forward P/E
PEG
P/S
68.98
P/B
5.06
P/Free Cash Flow
EPS
-2.57
Average EPS Est. Cur. Y
-5.27
EPS Next Y. (Est.)
0.99
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-2298.54
Relative Volume
0.93
Return on Equity vs Sector %
84.2
Return on Equity vs Industry %
113.5
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
◆
CAMP
Healthcare
$4.65
📉
N/A
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
10/20
Pullback
15/25
Volume
4/15
Valuation
8/20
TP/AR
2/10
Options
0/10
RSI
49.4
Range 1M
21%
Sup Dist
6%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
2/25
Growth
13/30
Estimates
0/20
Inst/Vol
7/15
Options
0/10
EPS Yr
70.6%
EPS NY
7.2%
52W%
52.7%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+76.3% upside
Quality
3/30
Valuation
12/30
Growth
8/25
Stability
6/10
LT Trend
2/5
Upside
+76.3%
Click a card to see score breakdown
Full Analysis →
Sector: Healthcare
Industry: Biotechnology
Employees: 48
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
CAMP
Latest News
—
Caricamento notizie per CAMP…
stock quote shares CAMP – CalAmp Corp. Stock Price stock today
news today CAMP – CalAmp Corp. stock forecast ,stock prediction 2023 2024 2025
marketwatch CAMP – CalAmp Corp. yahoo finance google finance
stock history CAMP – CalAmp Corp. invest stock market
stock prices CAMP premarket after hours
ticker CAMP fair value insiders trading